Royal Bank Of Canada Medi Wound Ltd. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.35 - $9.8 $349 - $2,538	259 Added 87.21%	556 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.35 $160 - $284	-121 Reduced 28.95%	297 $1,000
Q1 2022 May 16, 2022	BUY	$1.86 - $3.24 $777 - $1,354	418 New	418 $1,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $798M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.